Literature DB >> 25367059

Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult.

Mekala R Raman1, Heather J Wiste1, Matthew L Senjem1, Chadwick P Ward1, Clifford R Jack1, Kejal Kantarci2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25367059      PMCID： PMC4239833          DOI： 10.1212/WNL.0000000000000957

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

2.  Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.

Authors:  Steven M Greenberg; Thomas Grabowski; M Edip Gurol; Maureen E Skehan; R N Kaveer Nandigam; John A Becker; Monica Garcia-Alloza; Claudia Prada; Matthew P Frosch; Jonathan Rosand; Anand Viswanathan; Eric E Smith; Keith A Johnson
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422
  2 in total
  2 in total

Review 1.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

Review 2.  Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy.

Authors:  Jacopo C DiFrancesco; Martina Longoni; Fabrizio Piazza
Journal:  Front Neurol       Date:  2015-09-25       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.